INTRODUCTION
============

Hypodontia, the congenital absence of one or a few teeth, is one of the most common developmental alterations of human dentition. Hypodontia is not a serious public health problem, but it may cause masticatory (temporomandibular joint disorders) and speech dysfunctions and create esthetic problems with orthodontic and prosthetic impairments[@B29]. In the past few years, several growth and transcription factors have been shown to be expressed in developing teeth[@B26]. The direct participation of several genes in tooth development was demonstrated by the lack of teeth in mutant knockout mice models[@B07]. Autosomal dominant forms of hypodontia have been shown to be caused by mutations in the MSX1 and *PAX9* genes in human families[@B25]. However, the origin of the isolated sporadic agenesis, the most common form of hypodontia in humans, is still unknown. To date only a limited number of mutations of MSX1 and *PAX9* have been proven to be associated with severe hypodontia (oligodontia) in humans[@B11].

*PAX9* is a transcription factor that is expressed in dental mesenchyme at initiation, bud, cap and bell stages of odontogenesis[@B15]. Protein products of this gene serve as transcription factors that are responsible for the crosstalk between epithelial and mesenchymal tissues and are essential for the establishment of the odontogenic potential of the mesenchyme[@B23],[@B27]. It has been found that *PAX9*-deficient mice lack teeth and pharyngeal pouches derivates and have severe craniofacial anomalies[@B16]. The expression of *PAX9* in the mesenchyme appears to be a marker for the sites of tooth formation as it occurs before any morphological manifestation of this process[@B12]. Mutations in this gene have been shown to be associated with autosomal dominant forms of oligodontia (agenesis of more than 6 teeth, MIM 604625) in humans[@B10],[@B25]. In most families, mutations occur in exon 2 affecting the function of *PAX9* paired domain that is responsible for the binding of this protein to DNA target sequences. Affected individuals have severe tooth agenesis with absence of most molars, second premolars and some incisors. *PAX9* is critical for the regulation of BMP*4* expression through its paired domain rather than Msx1[@B13].

Polymorphisms are a mechanism by which individuals may exhibit variations within the range of what is considered biologically normal. Gene polymorphisms have also been associated with susceptibility to diseases. Most polymorphisms are single nucleotide exchanges that occur at a high frequency in the human genome and may affect the function of genes. Although it has been demonstrated that mutations in the coding sequences of *PAX9* are a causative factor in familiar forms of severe tooth agenesis, polymorphisms in this gene have not been associated with sporadic tooth agenesis.

Previous studies have shown that two polymorphisms in the *PAX9* promoter region seem to be associated to the dental agenesis in human beings (G-1031A, T-912C T-160C). The purpose of the present study was to investigate whether the G-915C single nucleotide polymorphism (SNPs) in the *PAX9* gene promoter is associated with hypodontia in humans[@B15],[@B22].

MATERIAL AND METHODS
====================

Subject Selection and Sampling
------------------------------

One hundred and thirty unrelated Caucasian individuals with hypodontia, without signs of other disorders and 110 healthy control individuals (without hypodontia) were interviewed and documented. Congenital absence of teeth was confirmed by X-ray examination. No other dental anomalies were observed in the subjects. The sampling of epithelial buccal cells was performed as previously described[@B15]. Briefly, individuals undertook a mouthwash of 5 mL 3% glucose. Following mouthwash, a sterile wooden spatula was used to scrape oral mucosa. The tip of the spatula was then shacked into the retained mouthwash solution. Buccal epithelial cells were pelleted by centrifugation at 2000 rpm for 10 min. The supernatant was discarded and the cell pellet resuspended in 500 µL extraction buffer \[10 mM Tris-HCl (pH 7.8), 5 mM EDTA, 0.5% SDS\]. The samples were then frozen at -20°C until used for DNA extraction. After defrosted, samples were incubated overnight with 100 ng/mL proteinase K (Sigma Chemical Co., St. Louis, MO, USA) at 37°C with agitation. DNA was then purified by sequential phenol/chloroform extraction and salt/ethanol precipitation. DNA was dissolved in 70 µL TE buffer \[10 mM Tris (pH 7.8), 1 mM EDTA\]. The concentration was estimated by measurements of OD 260[@B15].

Polymerase Chain Reaction (PCR)
-------------------------------

Amplification of the *PAX9* gene fragment was performed with the oligonucleotides 5'AGC CTG AAT CCT GTG TGC AC-3′ (forward) and two reverses to amplify the region with alleles G or C. To amplify the alelles G the oligonucleotide 5'GAA ATA TTT TCG TGA ATT TGG GAG'-3′ was used and the C allele was amplified with the oligonucleotide 5'ATT TTC GTG AAT TTG GGAC'-3′ (NCBI ref SNP ID: rs 2073245). Reactions were conducted in a total volume of 50 ìL, containing: 10 mM Tris-HCl (pH 8.3), 50 mM KCl, 1 mM of each primer, 200 mM each dATP, dCTP, dGTP and dTTP, 25 mM MgCl2 and 2.5 units Taq DNA polymerase (Amersham Pharmacia Biotech, Uppsala, Sweden). The thermal cycling conditions consisted of an initial denaturation at 95°C for 5 min followed by 35 cycles of 95°C for 60 sec, annealing at 56°C for 70 sec, and a final extension at 72°C for 70 sec. Reactions were performed on a *GeneAmp^®^ PCR System 2400* thermocycler (Perkin Elmer).

PCR products of *PAX9* were submitted to 10% polyacrylamide gel electrophoresis and the DNA bands were labeled by silver staining[@B15].

Statistical Analysis
--------------------

The significance of the differences in observed frequencies of polymorphisms in both groups was assessed by odds-ratio and chi-squared test with 95% confidence interval. All statistical analysis was conducted using BioEstat program version 2.0. Differences were considered significant at p\<0.05[@B15].

RESULTS
=======

The statistical analysis showed significant differences in the alleles and genotypes frequencies in the promoter polymorphisms of *PAX9* gene (G-915C). The C allele was found in 31.4% of the control group and in 42.5% of the test group (individuals with hypodontia) (p=0.0014). The G/G and C/C genotypes frequencies were 39.1% and 1.8% in the control group and 26% and 11.4% in the test group respectively (p=0.0045). The frequencies of different alleles and genotypes of the *PAX9* gene are shown in [Table 1](#t01){ref-type="table"}. The association was confirmed when the CC genotype is confronted with CG/GG. Individuals with CC genotype seemed to be seven times more susceptible to develop hypodontia (OR= 7.04; 95% CI= 1.1-15.2; p*=* 0.0034).

###### Genotype and allele distribution of the G-915C polymorphism of *PAX9* gene in the control and hypodontia (third molar) groups

  G-915C       Control   Third molar agenesis         
  ------------ --------- ---------------------- ----- ----------------
  Genotype     n         \%                     n     \%
  GG           43        39.1                   34    26.2
  GC           65        59.1                   81    62.4
  CC           2         1.8                    15    11.5
  p                                                   0.0045
  CC           2         1.8                    15    11.5
  GG/GC        108       98.2                   115   88.5
  p\*                                                 0.0034
  OR (95%Cl)                                          7.04(1.1-15.2)
  Allele       n         \%                     n     \%
  G            151       68.6                   150   57.5
  C            112       31.4                   110   42.5
  p                                                   0.0014

\>*p\**: chi-squared test.

DISCUSSION
==========

The G-915C polymorphism in the 5' flanking region of *PAX9* gene could be associated with hypodontia in humans. CC genotype was found at a significant higher frequency in individuals with hypodontia. Analysis of human families shows a strong effect of *PAX9* mutations on third molar agenesis, whereas mutations in this gene have a weaker but fairly evident effect on the development of incisors and premolars.[@B04]--[@B06],[@B18]--[@B20],[@B24],[@B28]. Three other polymorphic alleles (T-160C, G--1031A and T--912C) located close to the polymorphic region evaluated here were also associated with hypodontia in humans[@B22].

Families bearing *PAX9* mutation had tooth agenesis as the only clinical sign. The relative lack of pleiotropy of mutations in *PAX9* and on other genes affecting the dental field would account for the common variation in the form and number of teeth observed in humans and other mammals[@B02]. This would allow genetic changes to affect the earlier phases of tooth development, without interfering significantly with the development of other organs[@B16].

Experimental and theoretical approaches have stressed the importance of cis-regulatory DNA sequences that control the transcription of genes as the basic modular unit that determine the positional information in developing structures[@B03]. The *cis*-regulatory sequences of many genes are organized into independent modules that regulate the transcription of specific tissues at specific times during development\'. The regulatory modules are usually constituted of multiple binding sites for transcription factors that can be located near the transcription start site, or thousand of base pairs away[@B01]. Mutations within individual modules can enhance or repress gene transcription in a tissue specific manner, allowing a mutation to exert its effect on a few or even a single morphogenetic field[@B07]. A relevant fact is the relative lack of pleiotropic effects of *PAX9* gene mutations in humans. Families bearing *PAX9* mutation had tooth agenesis as the only clinical sign. The relative lack of pleiotropy of mutations in *PAX9* gene and on other genes affecting the dental area would account for the common variation in the form and number of teeth observed in humans and other mammals[@B02]. This would allow genetic changes to affect the earlier phases of tooth development, without interfering significantly with the development of other organs.

For example, the down-regulation of *Msx1* expression in *PAX9*-deficient mice and decreased levels of *Bmp4* expression in *PAX9* and *Msx1* homozygous null mice indicate that the three genes act within the same signaling pathway. Although recent studies of human *PAX9* mutations have enabled structure-function correlations, the precise molecular mechanisms that contribute to tooth agenesis are poorly understood. The functional studies of a previously described mutation (L21P) in the amino-terminal

subdomain of the *PAX9* paired domain demonstrate impaired transcriptional activation of the Msx1 and Bmp4 promoters. It is likely that the proline cyclic side chain blocks the main chain nitrogen atom and chemically prevents it from forming a hydrogen bond[@B13].

In humans, the changes in the number of teeth tend to occur in the reverse of the sequence that teeth are formed during development, which also characterizes the general pattern of tooth loss observed during the evolution of placental mammals[@B17]. Variations in tooth number may have represented an important factor in the diversification of mammalian species. Like hypodontia, most evolutionary changes in tooth number resulted from the loss of one or two elements, in most cases the last member of a tooth family. In this regard, the study of genetic polymorphisms in tooth agenesis is a specially suited model to understand the association of gene polymorphisms and changes in morphology. Teeth are serially homologous structures and the effects of gene variations on the development of these structures can be easily quantified[@B08]. Individuals with distinct polymorphic alleles may exhibit subtle and specific phenotypic variations in dental patterning. In this sense, association studies between gene polymorphisms and hypodontia as well as other mild malformations that reflect qualitative defects of embryogenesis[@B14], may help understanding the molecular mechanisms responsible for the phenotypic variations that may occur in distinct human populations and ethnic groups.

The first mutation described in human *PAX9* gene was an insertion of an additional G within the paired box sequence at nucleotide 219 (219InsG) of exon 2 in a family with oligodontia. Since then eight additional mutations in the coding region of *PAX9* gene were reported being associated with oligodontia in humans[@B08]. Seven out of the nine reported mutations were located in the paired domain at exon 2. Recently, it has been shown that the 219InsG frameshift mutation dramatically reduces DNA binding of the *PAX9* paired domain and supports the hypothesis that loss of DNA binding is the pathogenic mechanism by which the mutation causes oligodontia[@B09]. Although mutations in the coding sequences of *PAX9* and *MSX1* genes are a causative factor in familiar forms of oligodontia[@B06], the genetic origin of the isolated sporadic agenesis, the most common form of hypodontia in humans, is still unknown. We report here that three other polymorphisms (T-160C, G-1031A and T-912C) in the 5' flanking region of *PAX9* gene are associated with hypodontia in humans. Other alleles, such as C (-160), A (-1031) and C (-912) were found at a significant higher frequency in individuals with hypodontia. A comparative analysis of mouse, rat and human *PAX9* 5' flanking sequences shows that the T-160C is located in a poorly conserved region when human and rodent (mice and rat) sequences are compared. Although the present study showed a positive association on genotype and odds ratio, the results must be confirmed by studies with other populations and functional experiments, such as homologous recombination in mice, gel shift analysis and reporter gene systems.

CONCLUSION
==========

The findings of this study showed that the allele C could be associated with third molar agenesis.
